SOLVE FSHD AnnouncesNew Collaborative Research Grants to Accelerate Novel Potential Therapeutics for Facioscapulohumeral Muscular Dystrophy (FSHD)
VANCOUVER, B.C., July 11, 2023 – SOLVE FSHD, a venture philanthropy organization catalyzing innovation and removing barriers to accelerate new therapies for FSHD, announced today that it has awarded grants totalling USD $1.4M to four new collaborative research projects that address critical gaps in FSHD therapeutics, biology and/or biomarkers.
The four grant recipients represent relationships formed between academic and industry researchers during SOLVE FSHD’s inaugural conference in Whistler, British Columbia. SOLVE FSHD’s focus and venture philanthropic funding model supports the organization’s goal of generating new approaches to identify or evaluate therapeutics to find a cure for FSHD. These projects demonstrate how the expertise of lead investigators can be enhanced through strategic collaboration with other experts working on areas of mutual interest. All funding decisions were independently made by SOLVE FSHD and its designated review panel.